Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
127 Leser
Artikel bewerten:
(0)

Black Book Market Research LLC: ModMed Named Leader in Physician Practice EHR Software for 11 Specialties in 2025 Black Book Awards

Finanznachrichten News

TAMPA, FLORIDA / ACCESS Newswire / January 16, 2025 / ModMed continues to dominate the field of physician practice electronic health record (EHR) software, earning top honors in the 2025 Black Book Research Awards across 11 medical specialties. Recognized for its ability to deliver tailored, innovative EHR solutions that meet the distinct needs of diverse physician practices, ModMed solidifies its position as the trusted choice for specialty care providers.

ModMed's specialty-specific EHR solutions were ranked first in multiple specialties, marking an enduring legacy of leadership and innovation. Since 2010, nearly a quarter of a million physician practices have participated in the Black Book EHR user polls. The specialties and consecutive years of top specialty recognition for ModMed in the Black Book surveys include:

  • Gastroenterology - 15 consecutive years

  • Dermatology - 12 consecutive years

  • Otolaryngology (ENT) - 11 consecutive years

  • Plastic Surgery - 10 consecutive years

  • Ophthalmology - 9 consecutive years

  • Orthopedics - 8 consecutive years

  • Pain Management - 5 consecutive years

  • Podiatry/Foot & Ankle - 4 consecutive years

  • Urology - 4 consecutive years

  • Allergy & Immunology - 2 consecutive years

  • OB/GYN & Fertility Medicine - 2 consecutive years

Black Book Research evaluated vendors on 18 critical key performance indicators (KPIs) essential to physician practices. ModMed excelled in categories vital to clinical and operational success, including:

Physician-Centric Design: Customizable workflows tailored to meet the unique requirements of each specialty, streamlining documentation, diagnosis, and treatment planning.

Interoperability: Seamless integration with labs, imaging systems, and external networks ensures efficient data sharing and coordination of care.

Scalability and Flexibility: Adaptable solutions designed to support practices of all sizes, from single providers to large multi-specialty organizations.

Workflow Optimization: Automation of administrative tasks, such as scheduling and reporting, reduces staff burden and improves practice efficiency.

Practice Clinical Decision Support: Embedded tools enhance diagnostic accuracy, improve patient safety, and align care delivery with evidence-based guidelines.

In addition to excelling in specialty-specific functionality, ModMed was lauded for its robust data security and HIPAA compliance, ensuring patient information remains protected. Its training and support services were praised for providing effective onboarding and ongoing assistance, helping practices maximize the platform's potential. ModMed's proactive approach to continuous improvement, including frequent updates and user-driven enhancements, further ensures practices remain ahead of industry changes and regulatory requirements.

"ModMed's EHR solutions consistently deliver the tools that physician practices need to excel," said Doug Brown, President of Black Book Research. "Their ability to tailor software to specialty workflows while maintaining interoperability, compliance, and user satisfaction makes them a leader in the field of electronic health records for specialty care."

About Black Book Research

Black Book Research has been a trusted authority in healthcare IT evaluations for over 16 years, specializing in polling physician practice EHR users to provide objective insights into the performance of electronic health record systems. Since its inception, more than 260,000 practices have participated in Black Book's comprehensive surveys, making it one of the most robust and reliable sources of client feedback in the industry. Renowned for its commitment to objectivity, Black Book operates free of vendor influence and remains unbiased in its evaluations. Its surveys thoroughly examine the client experience and user satisfaction, focusing on critical aspects such as system usability, functionality, interoperability, and vendor support, providing a comprehensive view of the strengths and challenges of medical and surgical practice EHR solutions to help practices make informed decisions and vendors improve their offerings.

Contact Information

Press Office
research@blackbookmarketresearch.com
8008637590

.

SOURCE: Black Book Market Research LLC



View the original press release on ACCESS Newswire

© 2025 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.